HU201071B - Process for producing new 9-(2-hydroxy-ethoxy-methyl)-guanin-esters and pharmaceutical compositions containing them - Google Patents

Process for producing new 9-(2-hydroxy-ethoxy-methyl)-guanin-esters and pharmaceutical compositions containing them Download PDF

Info

Publication number
HU201071B
HU201071B HU884332A HU433288A HU201071B HU 201071 B HU201071 B HU 201071B HU 884332 A HU884332 A HU 884332A HU 433288 A HU433288 A HU 433288A HU 201071 B HU201071 B HU 201071B
Authority
HU
Hungary
Prior art keywords
esters
pharmaceutical compositions
guanin
ethoxy
hydroxy
Prior art date
Application number
HU884332A
Other languages
English (en)
Other versions
HUT47935A (en
Inventor
Thomas Anthony Krenitsky
Lilia Maria Beauchamp
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26292613&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HU201071(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB878719367A external-priority patent/GB8719367D0/en
Priority claimed from GB878725939A external-priority patent/GB8725939D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of HUT47935A publication Critical patent/HUT47935A/hu
Publication of HU201071B publication Critical patent/HU201071B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Description

Szabadalmas:
: THE WELLCOME FOUNDATION
LIMITED, London, (GB) ¢54) ELJÁRÁS 9— (2-HIDROXI-ETOXI-METIL ) —
-GUÁNXN-ÉSZTEREKfeS ILYEN VEGYÜLETEKET TARTALMAZÓ GYÓGYÁSZATI KÉSZÍTMÉNYEK ELŐÁLLÍTÁSÁRA (57) KIVONAT
A találmány tárgya eljárás (I) általános képletű 9- (2- hidroxi-etoxi- metil)- g uanin-észterek vagy gyógyászatilag alkalmas sóik előállításé- 5 ra, amelynél egy (II) általános képletű vegyületet adott esetben védett valinnal vagy izoleucinnal vagy ezek funkcionálisan egyenértékű származékával reagáltatnak, vagy egy (IV) általános képletű vegyületet és egy (V) 10 általános képletű vegyületet reagáltatnak, majd adott esetben - tetszés szerinti sorrendben i) eltávolítanak valamely védócsoportót, 15 ii) ha a kapott vegyület (I) általános képletű vegyület, azt gyógyászatilag alkalmas sójává alakítják és iii) ha a kapott vegyület az (I) általános képletű vegyület gyógyászatilag alkalmas sója, azt (I) általános képiétű vegyületté alakítják.
A képletekben
Rí jelentésé -CH(CHs)2 vagy -CH(CH3)CH2CHa csoport,
X jelentése adott esetben védett hidroxilcsoport,
Y jelentése adott esetben védett aminocsoport,
Q jelentése kilépő atom vagy csoport,
A jelentése kilépő atom vagy csoport és R2 jelentése adott esetben védett aminocsoport.

Claims (2)

  1. A vegyületekböl vírusellenes hatású gyógyszerkészítmények állíthatók elő.
    A leírás terjedelme: 14 oldalt 1 rajt, 4 ábra
    -1OH
    CH2OCH2CH2OH
    N lúr.w ( II ) .Y^Nf ^N' ó (, iv i ach2 och2ch2oqochiír,jr2 tv cí
  2. 2·
HU884332A 1987-08-15 1988-08-12 Process for producing new 9-(2-hydroxy-ethoxy-methyl)-guanin-esters and pharmaceutical compositions containing them HU201071B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878719367A GB8719367D0 (en) 1987-08-15 1987-08-15 Therapeutic compounds
GB878725939A GB8725939D0 (en) 1987-11-05 1987-11-05 Therapeutic compounds

Publications (2)

Publication Number Publication Date
HUT47935A HUT47935A (en) 1989-04-28
HU201071B true HU201071B (en) 1990-09-28

Family

ID=26292613

Family Applications (1)

Application Number Title Priority Date Filing Date
HU884332A HU201071B (en) 1987-08-15 1988-08-12 Process for producing new 9-(2-hydroxy-ethoxy-methyl)-guanin-esters and pharmaceutical compositions containing them

Country Status (30)

Country Link
EP (2) EP0596542B1 (hu)
JP (2) JPH0662623B2 (hu)
KR (2) KR960002849B1 (hu)
CN (1) CN1033701C (hu)
AP (2) AP160A (hu)
AT (1) ATE138660T1 (hu)
AU (1) AU612393C (hu)
CS (1) CS276903B6 (hu)
CY (1) CY1833A (hu)
DE (1) DE3855333T2 (hu)
DK (2) DK170045B1 (hu)
ES (1) ES2087639T3 (hu)
FI (1) FI89713C (hu)
GR (1) GR3020372T3 (hu)
HU (1) HU201071B (hu)
IE (1) IE65551B1 (hu)
IL (1) IL87434A (hu)
LU (1) LU88746I2 (hu)
LV (1) LV5264A3 (hu)
MC (1) MC1968A1 (hu)
MX (1) MX9203418A (hu)
MY (1) MY103760A (hu)
NL (1) NL960001I2 (hu)
NO (2) NO167805C (hu)
NZ (1) NZ225809A (hu)
PL (1) PL158285B1 (hu)
PT (1) PT88261B (hu)
SA (1) SA95160244B1 (hu)
SG (1) SG26346G (hu)
SU (1) SU1634138A3 (hu)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.
GB8816760D0 (en) * 1988-07-14 1988-08-17 Wellcome Found Therapeutic compounds
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
AU618436B2 (en) * 1988-12-19 1991-12-19 Wellcome Foundation Limited, The Antiviral cytosine and guanine derivatives
DE4008858A1 (de) * 1990-03-20 1991-09-26 Hoechst Ag Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel
ES2157259T3 (es) * 1993-06-10 2001-08-16 Rolabo Sl Procedimiento para preparar esteres de aminoacidos y analogos de nucleosidos.
GB9317146D0 (en) * 1993-08-18 1993-10-06 Wellcome Found Therapeutic combinations
GB9320316D0 (en) * 1993-10-01 1993-11-17 Smithkline Beecham Plc Pharmaceuticals
TW282470B (hu) * 1993-11-18 1996-08-01 Ajinomoto Kk
DE69513313T2 (de) * 1994-02-01 2000-07-13 Ajinomoto Kk Verfahren zur Herstellung von Nukleinsäurebasenderivaten
US5840891A (en) * 1994-07-28 1998-11-24 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
PE32296A1 (es) * 1994-07-28 1996-08-07 Hoffmann La Roche Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables
GB9501178D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Guanine derivative
GB9501142D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Compounds for use in medicine
GB9501127D0 (en) * 1995-01-20 1995-03-08 Wellcome Found Tablet
DE19536164A1 (de) * 1995-09-28 1997-04-03 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 9-[(2-Hyroxyethoxy)methyl]guanin (Acyclovir)
DK0874631T3 (da) * 1996-01-19 2004-03-22 Glaxo Group Ltd Anvendelse af valaciclovir til fremstilling af et medikament til behandling af genital herpes ved en enkelt daglig anvendelse
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
ES2180923T5 (es) * 1996-01-26 2005-10-16 F. Hoffmann-La Roche Ag Proceso para la preparacion de derivados de purina.
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5869493A (en) 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
IT1283447B1 (it) * 1996-07-18 1998-04-21 Ind Chimica Srl Processo di preparazione del valaciclovir e relativi intermedi
AU5495898A (en) * 1997-01-17 1998-08-07 Ajinomoto Co., Inc. Novel z-valacyclovir crystals
AU4007699A (en) * 1998-05-21 1999-12-06 Mark Anderson A method for stimulation of defensin production by exposure to isoleucin
SK1592004A3 (sk) * 2001-09-07 2005-03-04 Teva Pharmaceutical Industries Ltd. Kryštalické formy valaciklovírus hydrochlóridu
WO2004000265A2 (en) 2002-06-24 2003-12-31 Ranbaxy Laboratories Limited Process for the preparation of robust formulations of valacyclovir hydrochloride tablets
US20050043329A1 (en) * 2002-09-06 2005-02-24 Shlomit Wizel Crystalline forms of valacyclovir hydrochloride
CN1309732C (zh) * 2002-10-28 2007-04-11 南京长澳医药科技有限公司 6－烷氧基－2’，3’－双脱氧鸟嘌呤核苷的制备方法
KR100871621B1 (ko) * 2003-06-02 2008-12-02 테바 파마슈티컬 인더스트리즈 리미티드 발라시클로비르 히드로클로라이드의 신규한 결정질 형태
CN1331471C (zh) * 2003-09-22 2007-08-15 陈云芳 盐酸万乃洛韦软胶囊组合物
CA2552560A1 (en) * 2004-01-21 2005-08-11 Teva Pharmaceutical Industries Ltd. Process for the preparation of valacyclovir hydrochloride
GB2413017A (en) * 2004-04-06 2005-10-12 Ford Global Tech Llc An electrical connector for a vehicle
WO2006035452A1 (en) * 2004-09-27 2006-04-06 Matrix Laboratories Ltd Novel pseudomorph of valaciclovir hydrochloride
WO2006127217A2 (en) 2005-05-25 2006-11-30 Eli Lilly And Company Cyclopropanecarboxylate esters of acyclovir
EP1746098A1 (en) 2005-07-21 2007-01-24 SOLMAG S.p.A. Valacyclovir polymorphs and a process for the preparation thereof
CN101456859B (zh) * 2009-01-06 2011-07-20 华南理工大学 抗病毒药物缬昔洛韦的制备方法
WO2011158252A1 (en) 2010-06-15 2011-12-22 Matrix Laboratories Ltd Process for the preparation of valacyclovir hydrochloride polymorphic form ii
CN102850354B (zh) * 2012-10-10 2014-07-23 山东金城医药化工股份有限公司 高纯度cbz-万乃洛韦的制备方法
CN106632335A (zh) * 2016-12-27 2017-05-10 河南康达制药有限公司 一种盐酸伐昔洛韦的制备方法
RU2750867C1 (ru) * 2020-05-18 2021-07-05 Александр Сергеевич Самойлов Производные гуанина

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
DE3534774A1 (de) * 1985-09-30 1987-04-02 Robugen Gmbh Nucleosid-analoge verbindungen mit antiviraler aktivitaet, verfahren zu deren herstellung sowie arzneimittel mit antiviraler wirkung
AP160A (en) * 1987-08-15 1991-11-18 The Wellcome Foundation Ltd Therapeutic acyclic nucleosides.

Also Published As

Publication number Publication date
EP0308065A3 (en) 1989-09-27
KR890003761A (ko) 1989-04-17
CN1032538A (zh) 1989-04-26
DK451388D0 (da) 1988-08-12
CS8805594A2 (en) 1990-06-13
MC1968A1 (fr) 1989-09-29
PL158285B1 (en) 1992-08-31
CN1033701C (zh) 1997-01-01
ATE138660T1 (de) 1996-06-15
JPS6468373A (en) 1989-03-14
FI883757A0 (fi) 1988-08-12
EP0596542B1 (en) 1996-05-29
PT88261A (pt) 1989-06-30
CY1833A (en) 1995-12-01
SU1634138A3 (ru) 1991-03-07
SG26346G (en) 1995-09-01
AU2097888A (en) 1989-02-16
KR960002849B1 (ko) 1996-02-27
EP0308065A2 (en) 1989-03-22
DE3855333D1 (de) 1996-07-04
FI883757A (fi) 1989-02-16
NO883612D0 (no) 1988-08-12
NO1996015I1 (no) 1996-12-17
FI89713B (fi) 1993-07-30
CS276903B6 (en) 1992-09-16
DK451388A (da) 1989-02-16
DK82694A (da) 1994-07-08
IE882463L (en) 1989-02-15
IL87434A (en) 1993-06-10
AP160A (en) 1991-11-18
MX9203418A (es) 1992-07-01
ES2087639T3 (es) 1996-07-16
HUT47935A (en) 1989-04-28
EP0596542A1 (en) 1994-05-11
AU612393C (en) 2006-08-17
NO167805B (no) 1991-09-02
JPH07113025B2 (ja) 1995-12-06
IE65551B1 (en) 1995-11-01
DK170803B1 (da) 1996-01-22
IL87434A0 (en) 1989-01-31
GR3020372T3 (en) 1996-09-30
FI89713C (fi) 1993-11-10
AP8800099A0 (en) 1988-08-01
MY103760A (en) 1993-09-30
PL274215A1 (en) 1990-02-19
AU612393B2 (en) 1991-07-11
PT88261B (pt) 1995-03-01
NO167805C (no) 1991-12-11
NO883612L (no) 1989-02-16
LV5264A3 (lv) 1993-10-10
NL960001I1 (nl) 1996-03-01
DK170045B1 (da) 1995-05-08
SA95160244B1 (ar) 2006-10-02
AP55A (en) 1989-09-26
EP0308065B1 (en) 1995-01-04
JPH0662623B2 (ja) 1994-08-17
JPH03115284A (ja) 1991-05-16
NZ225809A (en) 1991-07-26
DE3855333T2 (de) 1996-12-05
NL960001I2 (nl) 1996-11-01
KR960004940B1 (ko) 1996-04-18
LU88746I2 (fr) 1996-10-04

Similar Documents

Publication Publication Date Title
HU201071B (en) Process for producing new 9-(2-hydroxy-ethoxy-methyl)-guanin-esters and pharmaceutical compositions containing them
JP2788084B2 (ja) 抗ウイルス化合物
CZ283721B6 (cs) Purinové deriváty a jejich farmaceutické použití
HUP0103641A2 (hu) Vírusellenes purinszármazékok és ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
GR3020212T3 (en) Pyrimidine nucleosides
CA2083606A1 (en) Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
KR960004345A (ko) 2-(2- 아미노-1,6- 디하이드로-6- 옥소-퓨린-9-일)메톡시-1,3- 프로판 디올 유도체
JP2613352B2 (ja) パーキンソン病治療剤
IL69095A (en) 9-(2-hydroxyethoxymethyl)-guanine derivatives,their preparation and pharmaceutical compositions containing them
KR850700136A (ko) 신규 구아닌 유도체
ATE74603T1 (de) Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
CA2095613A1 (en) Substituted 1, 3-oxathiolanes and substituted 1, 3-dithiolanes with antiviral properties
IE60510B1 (en) 6-thioxanthines
IE861875L (en) Poly-4-aminopyrrole-2-carboxamido derivatives
JPH05509307A (ja) プリンの抗ウイルス性ホスホノ―アルケン誘導体
DE69534745T2 (de) Immunopotenzierende 5'-nucleotidase-resistente inosinmonophosphat-derivate und ihre verwendung
WO1992009611A1 (en) Pharmaceuticals
KR890013028A (ko) 세팔로스포린 유도체 및 이의 제법
JPH10508032A (ja) アリールチオキサンチン類
US4085214A (en) Stable pro-drug forms of theophylline
ATE30724T1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten.
US5446045A (en) Antiviral guanine analogs
DE69118016T2 (de) Cyclobutan-Derivate
AU701739B2 (en) Use of penciclovir for the treatment of human herpes-virus-8
WO2000051615B1 (en) Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor